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Abstract
Currently, no available pathological or molecular measures of tumor angiogenesis predict response to antiangiogenic
therapies used in clinical practice. Recognizing that tumor endothelial cells (EC) and EC activation and survival signaling are
the direct targets of these therapies, we sought to develop an automated platform for quantifying activity of critical
signaling pathways and other biological events in EC of patient tumors by histopathology. Computer image analysis of EC in
highly heterogeneous human tumors by a statistical classifier trained using examples selected by human experts performed
poorly due to subjectivity and selection bias. We hypothesized that the analysis can be optimized by a more active process
to aid experts in identifying informative training examples. To test this hypothesis, we incorporated a novel active learning
(AL) algorithm into FARSIGHT image analysis software that aids the expert by seeking out informative examples for the
operator to label. The resulting FARSIGHT-AL system identified EC with specificity and sensitivity consistently greater than
0.9 and outperformed traditional supervised classification algorithms. The system modeled individual operator preferences
and generated reproducible results. Using the results of EC classification, we also quantified proliferation (Ki67) and activity
in important signal transduction pathways (MAP kinase, STAT3) in immunostained human clear cell renal cell carcinoma and
other tumors. FARSIGHT-AL enables characterization of EC in conventionally preserved human tumors in a more automated
process suitable for testing and validating in clinical trials. The results of our study support a unique opportunity for
quantifying angiogenesis in a manner that can now be tested for its ability to identify novel predictive and response
biomarkers.
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Introduction
Cancers are a complex community of different cell types with
the transformed tumor cell population usually receiving primary
attention. Cells of the tumor stroma, often considered secondary,
provide essential support for tumor cells and are increasingly
recognized for their contributions to the malignant behavior of
cancers [1]. Among stromal cells, the importance of endothelial
cells (EC) is widely recognized, which has led to the development
[2,3] and clinical adoption [4,5] of treatments targeting tumor EC
as a way of controlling tumor growth and spread. The
pathophysiologic and therapeutic significance of EC in cancer
biology suggests the need to study and characterize EC in patient
tumors. However, there have been few efforts to study these cells
in human cancers beyond assessing the density and limited
characteristics of microvessels [6,7,8]. Low numbers, inconspicu-
ous and pleiomorphic appearance and dispersal throughout the
disorganized architecture of tumors make systematic visual
identification of EC in histopathology very challenging. Biomarker
staining can facilitate EC identification but adds to the complexity
of visual inputs that observers must process (Fig. S1). Given the
necessary expertise, time, and labor, visual analysis of cancer EC is
not practical on a clinical scale.
Based on prior studies in mouse tumor models [9,10], we
wanted to examine biological events, such as proliferation and
activation of signaling pathways, in EC of human tumors to
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understand their biology in real cancers and identify potential
metrics of tumor angiogenic activity. EC in human renal cell
carcinomas (RCC) were of particular interest because deregulated
angiogenesis features prominently in the pathogenesis of these
tumors [11], and anti-angiogenic agents are preferred treatment
for patients with metastatic RCC [12]. The goal of characterizing
RCC EC in patients entered in therapeutic clinical trials meant
that tumors from many patients would need to be studied, and a
computer-assisted approach to analysis would be needed. To this
end, we developed a novel image analysis platform to perform
selective molecular imaging of patient tumor tissue, accurately
delineating structures and reliably identifying cell types of interest
using the FARSIGHT software platform [13].
Performing comprehensive, cytometric analysis of EC from
tumor images is predicated on the identification of individual cells
present in the tumor and their classification into cell types of
interest. We developed a hybrid nuclear segmentation algorithm
(Methods Section) that delineates individual nuclei in the image
resulting in a label map that defines the presence of all nuclei. The
label map allows the computation of quantitative measurements
(referred to as features) that describe the shape, size, texture and
intensity of associated biomarkers for individual nuclei. These
features are provided as an input to a classification algorithm that
learns different classes of cells from the training examples and
labels provided by an expert. In the traditional classification
paradigm, the user sifts through a pool of unlabeled cells and
provides class labels (e.g. endothelial cell or tumor cell) for a subset.
The labeled subset is provided as an input to the algorithm which
uses these features and labels to construct a mathematical model
and classify all the cells present in the dataset. However, human
trainers can spend considerable effort providing many uninfor-
mative examples, because they cannot judge the quantitative
contribution of an example to the learning task. Also, when the
analysis is performed at the scale of clinical trials with hundreds of
thousands of cells, selecting useful examples can be an effort-
intensive proposition. Unaided, they can introduce subjectivity
and selection bias into the learning process which might hurt
classification performance. In order to make the training objective
and minimize the training effort, we adapted and improved a
novel active learning algorithm developed originally for Unexplod-
ed Ordnance Cleanup [14].
The fundamental idea behind active learning (AL) is that not all
training examples are equally useful for classification. Based on
what we know about the cells by observing the labels for a few
training examples, labels of certain examples are more useful than
others. By focusing on these examples iteratively, the algorithm
can learn the problem more quickly and classify the data more
accurately. AL algorithms sequentially select the most informative
cells from the large unlabeled pool and query the user for their
labels. Based on how the notion of information is defined, several
active learning methods have been proposed. One of the most
popular frameworks is the Uncertainty Sampling where the
algorithm queries for examples that it is most uncertain about. It is
commonly used with margin based classifiers like SVM [15] and
also with probabilistic classifiers where the notion of uncertainity is
easily defined in terms of probabilities of the class. Query by
Committee methods [16,17] use an ensemble of classfiers and
query training examples that have the maximum disagreement in
their labeling by the committee members. Expected Error
Reduction methods [18,19] query those examples that reduce
the future generalization error of the classifier and are computa-
tionally expensive. The proposed approach falls under the
category of Variance Reduction methods where examples that
reduce the variance and thereby the uncertainty in the parameter
estimates are chosen for labeling and information is quantified as a
derived quantity of the Fisher Information Matrix (Methods
Section). Active learning methods have found success in several
domains like text classification [15,17], microarray analysis [20],
information retrieval [21], recommender systems [22] etc. Active
learning methods have also been applied in the field of
histopathology with considerable sucess [23,24].
Traditionally, supervised classification algorithms also require
the users to select the best set of features that will help differentiate
between different cells of interest. The more discriminative the set
of features selected, the better the classification accuracy.
However, most feature selection algorithms require a representa-
tive training set apropri to select the best set of features for
classification. Other feature reduction methods involve exploiting
the information in the eigenstructure of the data and project the
original data into a latent space where the new features are linear/
non-linear combination of original features. Although effective, the
transparency of features is lost when latent space methods are used
and additional effort is required to interpret these results. Most
feature selection algorithms require the user to perform offline
analysis. To select the important features on the fly and obviate the
offline feature selection process, we improved the active learning
algorithm to automatically select the important features for
classification also, thereby freeing the user from expending
additional effort for deciding the relevant features for different
cell classification problems. The complex mathematics of the
proposed algorithm (see Methods for details) is hidden from the
user and it is integrated into the FARSIGHT software system with
graphical user interfaces that constantly update the user about the
progress of classification and the parameters being used, making
the classification process transparent and practically usable. The
results of our study indicate that the proposed approach enables
characterization of EC in human tumors that can be tested and
validated in clinical trials.
Results
Endothelial cell identification in human tumor
histopathology
Our study requires analysis of vascular EC in patient ccRCC
through automated analysis of large batches of multi-spectral
images of tumor slides immunostained for CD34 to reveal EC
(250–500 images/batch are common). We previously developed
FARSIGHT to analyze images and classify carcinoma cells based
on morphometric characteristics and association with epithelial
cytokeratin or other biomarker staining [25]. When we used
similar association rules to classify EC on a subset of ccRCC
images, the resulting classification had many errors when
compared to expert human EC classification of the same images.
To improve automated EC classification, we incorporated
supervised machine learning classifier algorithms (Kernel Partial
Least Squares, KPLS [26]) into FARSIGHT and developed
protocols for providing examples of EC and non-EC for training.
EC classification improved, but the primary goal of high specificity
of EC classification (.0.95) was achieved only in very few images,
and these tended to be the actual images used for training or
different images from the same or similar tumors. It also came with
considerable sacrifice in sensitivity. Results did not improve
substantially with the addition of carbonic anhydrase (CA) IX and
smooth muscle actin (SMA) immunostaining to highlight tumor
cells and pericytes, respectively, for exclusion during EC classifi-
cation. More training with additional examples of EC and non-EC
in the same or new images only improved classification marginally
or not at all. On closer inspection, the poor performance of these
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algorithms was discovered to be a result of the immense diversity
in both CD34 biomarker staining patterns as well as features of the
cells in the large image set, all part of the inescapable
heterogeneity of patient tumor samples. The training set, by
necessity, identified only a minor sub-group of EC that may not
exemplify the critical features or criteria for accurate classification
and, hence, performed poorly when applied on the entire dataset.
Supervised machine learning algorithms are effective only when
provided with labeled examples that capture all essential
information about the data for which predictions are sought. As
training samples selected exclusively by humans did not produce a
classifier that could classify EC in RCC reliably, we hypothesized
that performance would be optimized by incorporating a novel
active learning algorithm based on the logistic regression classifier
in FARSIGHT (FARSIGHT-AL).
To teach FARSIGHT-AL to classify EC in a set of tumor
images, the trainer provides one initial example of EC and non-
EC nuclei. The system then displays a list of cell features that can
be utilized for the current classification task. Since the algorithm
automatically selects the important features, we initially performed
a ‘‘blind’’ analysis where all the computed features (Table S1 in
File S1) were provided as inputs to the algorithm. We refer to this
mode of the algorithm as ‘‘auto-select’’ mode in contrast to
‘‘manual-select’’ mode where an expert personally selects the
relevant features for classification. In our study, experts were
trained pathologists and an analyst trained in EC analysis in
human histopathology specimens. The algorithm searches the
feature measurements of all segmented cells and presents the cells
with features that result in the maximum information gain
(computed via the Fisher information matrix) for the trainer to
label. Based on the response of the trainer, the algorithm updates
its parameters, selects the best set of features that explain the
classification of the current labeled set and also computes the most
informative cells for the user to label in the next iteration. After
each iteration, the algorithm computes the increase in maximum
information gain and automatically senses convergence of its
evolving EC classification model when the increase in information
gain attains a plateau. The algorithm also updates the user
interface that displays a set of informative plots and heatmaps
indicating the state of the algorithm. The interface also allows the
user to explore the features of cells in different views allowing the
user to explore the parameter space comprehensively (Fig. 1).
Upon convergence, FARSIGHT-AL proceeds to classify all cells
as EC or non-EC and overlays a class-specific color-coded dot on
the cells for user verification. The EC classification model
developed by FARSIGHT-AL using one set of images can be
archived and used to classify EC in other images.
We created a set of 20 images of stained ccRCC tumors from
five different patients (ccRCC20 image set) with which to train and
test the program (Fig. S1 shows a typical image analyzed). A total
of 8,360 cells segmented by the FARSIGHT-AL nuclear
segmentation algorithm were manually classified by a pathologist
(trainer 2 in subsequent results) to train and evaluate the
performance of the algorithm. 50 active learning iterations were
performed to select the most informative cells from the unlabeled
pool. The algorithm automatically weighted the features based on
their discriminative capacity for the classification task and
automatically set the weight of uninformative features to (nearly)
zero, thereby nullifying their participation in the learning process.
The performance of our algorithm was evaluated using classifica-
tion accuracy as the metric and compared to that of the
‘‘standard’’ logistic regression classifier that chooses training
examples randomly without any explicit criterion to select
discriminative features. The proposed algorithm outperformed
standard logistic regression and its performance was more reliable
(Fig. 2 (A)). We also compared the performance of our algorithm
with other feature selection algorithms: Prinicpal Component
Analysis (PCA), Univariate Feature selection via t-test (T-Test)
[27] and Minimum Redundancy-Maximum Relevance (MRMR)
[28]. PCA uses the spectral information and captures the direction
of maximum variance in the data by projecting the data on the
principal components which are the eigen vectors of the
covariance matrix of the data. The simple univariate feature
selection method assumes that there is no interaction between the
features and applies a univariate criterion i.e., the t-test on each
feature and compares the p-value for each feature to determine its
effectiveness in separating the classes. The MRMR feature
selection algorithm uses mutual information criteria to compute
the optimal set of features that are maximally different from each
other but at the same time highly correlated with the classification
variable. The comparison of performance of these feature selection
algorithms with the proposed algorithm for ccRCC (in addition to
three other datasets; see Endothelial cell classification in different
tumor types section for details) is shown in Figure 2(a). It can be
seen that, although the proposed algorithm starts off slowly, after
enough number of training examples (50 in our experiments), our
algorithm performs as well as or better than the other algorithms.
In our experiments, MRMR and T-test achieved optimum
performance faster in all cases, although performance is matched
by our active learning algorithm eventually. For the STS dataset,
both MRMR and T-Test selected the same features and hence the
classifier performance is identical for both these feature selection
methods and the accuracy curve in orange indicates the
performance of both MRMR and T-Test. The ‘‘slow start’’ of
the active learning algorithm can be attributed to the fact that the
proposed algorithm is working on the full training set using all the
features and gradually makes decisions about the importance of
features, whereas with the other algorithms the feature selection
has already been performed and the classifier is working off the
reduced feature set from the beginning. However, the proposed
algorithm is much easier to use as the user can simply load the
feature data and classify the data. The proposed algorithm
achieved an estimated sensitivity of 0.942, specificity of 0.978,
positive predictive value (PPV) of 0.883 and negative predictive
value (NPV) of 0.989 (estimations used a model-based approach
that accounts for correlation between nuclei due to clustered
sampling). The results showed that the machine achieved the
desired high level of specificity accompanied by excellent
sensitivity. We also compared the performance of algorithms on
the Wisconsin Breast Cancer (Diagnostic) dataset from the UCI
Machine Learning Repository [29]. The features in this dataset
are computed from a digitized image of a fine needle aspirate
(FNA) of a breast mass and describe characteristics of the cell
nuclei present in the image. The performance of the proposed
algorithm is again similar to its performance on previous datasets,
and in case of the UCI-II (UCI Wisconsin Diagnostic Dataset), the
proposed algorithm outperforms the others (Fig. S2).
Although the performance of the algorithm in auto-select mode
met expectations in all the datasets, we wanted to compare its
classification performance in manual-select mode. To test this
approach, the trainer selected the features to be used for EC
classification (CD34 average, CD34 total, CD34 surround and
elongated morphology) and allowed the algorithm to select only
the informative training examples for which the user provided the
labels. When compared with the auto-select mode, the algorithm
with manual feature selection achieved a comparable specificity
value (0.998) and PPV (0.99) but the performance degraded
slightly with respect to sensitivity (0.93) and NPV (0.988). (Table 1).
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Aware that human experts disagree frequently on which cells
are EC in images, we evaluated how machine EC classification
depended on its training. Two additional experts trained FAR-
SIGHT-AL (in auto-select mode) to classify EC using the
ccRCC20 image set and also personally classified EC in these
images. Venn diagrams (Fig. 3) show the differences in EC
classification by the three trainers and by the FARSIGHT-AL
classification models created by them. For example, of cells
classified as EC by at least one expert,,64% were classified as EC
by all three, and ,21% were classified as EC by only one. Trainer
1’s manual classification calls agreed more with those of trainer 2
(,73%) than with those of trainer 3 (,70%). Interestingly, EC
classification by each version of FARSIGHT-AL models agreed
better among each other than the manual classification by their
trainers. Once again, trainer 1’s classification model agreed better
with that of trainer 2 than trainer 3. Since classification models are
mathematical rules, they tend to smooth out inconsistent
classification calls, to which humans are susceptible, but preserve
the overall preferences and idiosyncrasies of trainers. When
agreement was quantified by pair-wise Cohen’s kappa statistics
(Table 2), the best agreement with each trainer’s classification was
achieved by the FARSIGHT-AL version that he/she trained
(0.926 for trainer 1, 0.888 for trainer 2, 0.856 for trainer 3),
meaning that the model generated by FARSIGHT-AL based on a
trainer’s selection conformed more closely to his/her preferences
than any other trainer or model. Table S3 in File S1 shows the
agreement matrices for EC classification with the FARSIGHT-AL
models created by the three trainers.
Figure 1. FARSIGHT–AL software interface. The FARSIGHT-AL software interface integrates multiple views of the image data in a linked manner.
Image view (A) allows the user to adjust the complexity of visual input with respect to the number of biomarkers he/she wishes to view. It also shows
the pre-algorithm mask image to illustarte the detection capability of the software. The Scatterplot view (B), Histogram view (C), and Table View (D)
enable the user to visualize the data in ways intended to extract different types of information. All the views are hot-linked i.e., a cell selected in
the image view is highlighted in the scatter plot and table views as well (indicated by arrows). FARSIGHT-AL query window (shown in (E)) displays the
informative examples selected by the algorithm for labeling along with an image snapshot of the cell. The 5 most important features selected by the
algorithm are also displayed to the user. The evolving heatmap (F) shows an emerging structure with the active learning iterations (from i-vi) that
provide an indication of convergence of classification.
doi:10.1371/journal.pone.0090495.g001
Figure 2. Comparison of FARSIGHT-AL performance with other feature selection algorithms. Mean classification accuracy of 25
independent simulations plotted as a function of number of training examples for differnet automated feature selection algorithms including
FARSIGHT AL (blue lines) on four different datasets. FARSIGHT-AL selected 50 training examples sequentially based on the increase in information
gain whereas logistic regression was used to classify examples after feature selection by PCA (green), T-Test (purple), MRMR (Orange). Standard
Logistic regression (red) with no feature selection performs poorly compared to other algorithms. The bars indicate standard error of the mean of
classification accuracy. For the STS dataset, the features chosen by MRMR and T-Test were identical which result in identical classifier performance
indicated by the orange line.
doi:10.1371/journal.pone.0090495.g002
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Endothelial cell classification in different tumor types
With FARSIGHT-AL trained to classify EC in ccRCC tumors,
we tested its ability to classify EC in other tumor types that had
been similarly stained. Since the cell-type identifications of the
three pathologists agreed reasonably, we used the classification
models obtained by training against trainer 2’s interpretations
only. We compared models where features were auto-selected or
manual-selected with human EC classification. EC were classified
in 22 images containing a total of 13,585 cells taken from seven
RCC tumors that were subtyped as non-clear cell (non-ccRCC
image set) and included papillary type I and type II and
chromophobe RCC. Comparison of the two models (Table 1)
with human classification revealed that both the classification
models achieved a high degree of specificity and sensitivity with
the model with manual feature selection outperforming the
automatic one slightly. The same models were also tested and
shown to be able to classify EC with high accuracy in a set of 25
images with 8,111 cells taken from several different soft tissue
sarcomas (STS image set) and a set of 20 images with 17,244 cells
taken of stained K1735 murine melanoma tumors (K1735 image
set). Thus, the classification model trained to classify EC in one
type of human tumor can classify EC accurately in other tumor
types, including those from other species. Table S2 in File S1
shows the agreement matrices with total cell numbers for each of
the tumor types.
Analysis of analyte expression in cells (analyte
classification)
Accurate classification of EC in tumors using FARSIGHT-AL
sets the stage for obtaining biologically meaningful information on
these cells. Our interest in and the potential clinical significance of
the biological activity of EC in tumors led us to train FARSIGHT-
AL to determine their cell proliferative and signal transduction
activities as reflected in EC expression of Ki67 and activated
signaling intermediates, p-ERK and p-STAT3. The characteristic
subcellular distribution and staining intensity of these analytes in
immunostained ccRCC tumors dictated how EC were assessed for
their presence: Ki67 and p-STAT3 are nuclear, and their
expression was assessed by quantifying staining within nuclear
boundaries drawn during segmentation; p-ERK is found in the
nucleus, cytoplasm or both and was assessed by quantifying
staining within a perimeter of two pixels (0.5 micron in images
taken at 400X magnification) beyond nuclear boundaries.
These factors and other distinctive characteristics of analyte
immunostaining (see Fig. S3) led us to analyze datasets for analytes
individually. The FARSIGHT user interface was modified to
allow the user to navigate through hundreds of images and specify
a threshold to classify cells as analyte-positive or analyte-negative.
An issue with quantifying analyte expression is the variability in
analyte background signal (DAB staining) among different tumors
and even among images from different regions of the same tumor.
Selecting a threshold to classify analyte-positive cells without
compensating for the background can result in many cells being
incorrectly classified as analyte-positive. We observed this effect in
Ki67 and p-STAT3 analyte channels with the p-ERK channel
being relatively free of background staining effects. Therefore,
both Ki67 and p-STAT3 channels were processed with a
background subtraction algorithm that computes the average
background signal (pixel intensity) and subtracts this value from
the pixel intensities of the image. Figure 4 shows the results of the
algorithm. It can be seen that when there is spurious background
signal present in the spectrally unmixed analyte channel, the
algorithm eliminates these effects (Fig. 4(A–C)) and does not
modify analyte images without spurious background signal
(Fig. 4(D–F)).
After performing background subtraction, cells classified as
analyte-positive were the ones with analyte expression greater
than the specified threshold. Trainer 2 manually classified every
cell in the ccRCC20 image set as analyte- positive or negative
and, treating this labeled set as ground truth, we validated the
thresholding method against it. The method yielded excellent
specificity and sensitivity (Table S3 in File S1). Figure 5(A)
shows plots of EC classification and analyte expression
performed on an image set from 22 ccRCC tumors (10–12
images/tumor). Figure 5(B) shows the plots in the case where
ECs were identified by the FARSIGHT-AL trainer 2 manual-
select model. The auto-select and manual-select models yielded
similar results, suggesting that FARSIGHT-AL auto-select
model does not exhibit substantial bias towards classifying
analyte-positive or -negative cells as EC. These results showed
that the fraction of segmented cells identified as EC in the 22
tumors varied considerably (Figure 5; range 0.0386–0.3085,
median 0.1294), but the median was significantly higher in these
ccRCC tumors (p = 0.0015, Wilcoxon rank sum test) than in six
papillary RCC tumors (range 0.0121–0.1126, median 0.0258)
that we also studied (Fig. S4). In a tumor that had both
ccRCC and papillary histologies, areas of the former had a
significantly higher percentage of EC than areas of the latter.
These results agree with the exceptional hypervascularity of
tumors with clear cell histology and support the accuracy of
FARSIGHT-AL EC analysis. Also notable is the wide variation
in expression of EC activation antigens among tumors from
different patients, with some showing comparatively low levels
of the parameters measured. Substantial variation among
different images from the same tumor also is evident for some
tumors, suggesting regional heterogeneity in analyte expression
and the possibility of ‘‘hot spots’’ of EC activation.
Discussion
We present a software system with a sophisticated machine
learning algorithm that is scalable and enables rapid, reproducible
and accurate classification of cells with selective quantification of
molecular analytes over subpopulations. It is responsive and
searches features of hundreds of thousands of cells in a matter of
seconds to present the user with the most informative cells for
labeling. A critical requirement of any algorithm when dealing
with human tumors is to adapt to the inherent variability present
in the tissue samples, and our results on ccRCC tumors indicate
that the algorithm performs very well in this regard. Moreover, the
classifier model generated to identify EC in ccRCC performed
similarly on data from different tumors from different species.
Since cancer histopathology studies often examine similar cells in
different tumor tissues, FARSIGHT-AL may save researcher time
and effort in cell classification by creating representative cell type
classification models that are broadly applicable and yield accurate
results when the imaging protocols are similar. Our studies with
multiple experts indicate that FARSIGHT-AL is malleable and
learns the nuances of trainer interpretations. The algorithm is
consistent and, as long as the initial examples and the labels
provided by the trainer are the same, the algorithm queries for the
same cells and yields the same final EC classification result; this
contrasts with human EC classification, which often shows
differences from occasion to occasion (data not shown).
An attractive feature of our system is the complete flexibility it
provides to the user in terms of automation and robustness to user-
selected settings. The auto-select mode requires minimal supervi-
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sion from the user; this ability of the algorithm may be especially
useful in cases where cell types of interest have not been stained
with a specific marker and training relies heavily on morphological
features that might not be easily specified. The system can be
integrated in clinical workflow and used by researchers easily as it
works without the need for careful parameter adjustments or
specialized training. The auto-select mode allows development of
accurate classification models when only images with the labeled
cells are available. The pathologist labeling the cells need not be
an expert in software, the software operator need not be expert in
histopathology, and the two only have to communicate and grade
results. All the algorithms and software have been integrated into
the open-source FARSIGHT toolkit (www.farsight-toolkit.org).
We quantified antigen expression in cells of interest by
determining the fraction of cells expressing a threshold level of
antigen. FARSIGHT-AL permits antigen quantification in other
ways. For example, the level of antigen expression in cells can be
determined just as easily and expressed numerically as the mean or
median or displayed graphically, resembling how flow cytometry
results are usually displayed. Had we interest in an additional cell
type in the tumors studied and could identify these cells with
specificity, FARSIGHT-AL permits classification of additional cell
types and allows characterization of two or more cell subpopu-
lations using the same images. Similarly, additional analytes can be
stained for and studied on the same slide and images, allowing
examination of analyte co-expression by cells. These potentials of
the ‘‘histocytometry’’ platform require development of corre-
sponding multiplex immunostaining protocols and minor modifi-
cation of existing FARSIGHT-AL algorithms.
The analytes chosen for initial study represent EC proliferation
and signaling pathways activated by mitogens and found in
angiogenic endothelium of mouse tumors and are expected to
report endothelial activation and angiogenic activity in human
tumors. Heterogeneity in their expression among patient ccRCC,
a cancer known for hypervascularity and involvement of
deregulated hypoxia response and angiogenesis in its pathogenesis,
was not anticipated. On the other hand, finding differing levels of
angiogenic activation and activity in patient tumors also should
not surprise considering the variation in histopathology among
ccRCC tumors, tumor size and stage at the time of resection, and
clinical behavior and course among patients. However, another
factor that may artifactually contribute to measurement variability
must be considered; how patient specimens are handled prior to
analysis. Tissue antigens are subject to enzymatic and oxidative
degradation, and phospho-antigens may be particularly susceptible
and labile. While we adopted stringent protocols for handling
tumor slides (e.g. immunostaining was performed soon after
cutting), information was unavailable about how tumors were
handled prior to fixation and embedding. As quantitative analysis
of biologically important antigens in patient cancers becomes
feasible, it highlights the need for quality control and standards in
the handling of clinical specimens to limit preanalytic variables.
Management of advanced RCC has been transformed by the
advent of therapeutic agents that target components of the VEGF
and other important EC signaling pathways [7]. Response to
treatment with these agents, however, is variable and cannot be
predicted for individuals on the basis of clinical, pathological or
tumor genetic data. The ability of FARSIGHT-AL to identify and
characterize EC in conventional histopathology specimens makes
it possible to study EC biology in patient tumors and analyze and
quantify activity of pathways that are either targeted or report on
the activity of molecules targeted. We are awaiting clinical data
about the patients whose tumors were characterized using
FARSIGHT-AL to determine whether the measured parameters
correlate with clinical outcome. This illustrates the opportunity for
insight into the vascular biology of cancers of individual patients
and potential discovery of rational predictive biomarkers of
antiangiogenic therapeutic response.
Materials and Methods
Ethics statement
The Institutional Review Board of the University of Pennsyl-
vania approved this study of renal cell carcinoma tumor samples
previously collected by the Eastern Cooperative Oncology
Group (ECOG) in their multi-institutional study protocol
ECOG2804. Patients enrolled in ECOG2804 provided written
informed consent for ECOG to collect tumor tissue previously
removed.
Tissue source
Human renal cell carcinoma specimens were obtained from the
University of Pennsylvania’s Department of Pathology & Labora-
tory Medicine’s clinical paraffin archive and the Eastern Coop-
erative Oncology Group (ECOG) pathology core lab (Northwest-
ern University, Chicago, IL) under IRB approval.
Tissue staining
5 micron sections of formalin-fixed, paraffin embedded tumor
tissues were deparaffinized and treated with citric acid monohy-
Table 1. FARSIGHT-AL EC classification performance metrics.
Sensitivity* Specificity{ PPVm NPVN Non-EC EC
Manual-select
Auto-
select Manual-select
Auto-
select Manual-select
Auto-
select Manual-select
Auto-
select (number) (number)
ccRCC20 image
set
0.93 0.942 0.998 0.978 0.990 0.883 0.988 0.989 7,037 1,323
non-ccRCC image
set
0.965 0.941 0.999 0.997 0.982 0.934 0.998 0.998 13,070 515
STS image set 0.966 0.933 0.997 0.994 0.960 0.922 0.997 0.995 7,415 696
K1735 image set 0.925 0.896 0.998 0.996 0.942 0.911 0.997 0.996 16,553 691
*Sensitivity = True Positive/(True Positive + False Negative).
{Specificity = True Negative/(True Negative + False Positive).
mPPV = True Positive/(True Positive + False Positive).
NNPV = True Negative/(True Negative + False Negative).
doi:10.1371/journal.pone.0090495.t001
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drate buffer (pH 6) at 75uC for 11 minutes prior to staining. The
antibodies used for immunostaining included rabbit monoclonal
anti-phospho-extracellular-signal-regulated-kinase (p-ERK), rabbit
monoclonal anti-phospho-signal transducer and activator of
transcription 3 (p-STAT3), mouse monoclonal anti-human Ki67
(Dako, Carpenteria, CA, USA), rabbit monoclonal anti-CD34
(Epitomics, Burlingame, CA, USA), mouse monoclonal anti-
carbonic anhydrase 9 (CA IX) [30], and Cy3-conjugated anti-
smooth muscle actin (SMA) (Sigma Life Science, St. Louis, MO,
USA). p-ERK, p-STAT3, and Ki67 analytes were detected by
immunohistochemistry with biotinylated species-specific secondary
antibodies and avidin-linked horseradish peroxidase (HRP) (ABC
kit, Vector Laboratories), followed by 3,3 diaminobenzidine (DAB,
Vector Laboratories). CD34 and CA IX were detected by 3-step
immunofluorescence using biotinylated species-specific secondary
antibodies followed by fluorescently-labeled streptavidin conju-
gates (Alexa Fluor 488 and Alexa Fluor 647) (Invitrogen, Carlsbad,
CA, USA). All slides were counterstained with hematoxylin after
immunostaining.
Multiplex staining protocols were developed to stain slides with
combinations of the above antibodies and chemicals to reveal
cellular compartments and antigens that report on cell type and
molecular analytes. A frequently used combination included
staining for a molecular analyte with DAB, CD34 with Alexa
Fluor 488, CA IX with Alexa Fluor 647, SMA with Cy3, and
nuclei labeled in hematoxylin (Fig. S1).
Tissue imaging
Multispectral images were captured using a VectraH multispec-
tral microscope and camera (PerkinElmer, Waltham, MA) at
400X magnification (8 bits/pixel depth) from 420 nm-720 nm at
20 nm wavelength intervals (brightfield mode) or 10 nm wave-
length intervals (fluorescence mode). NuanceH software (PerkinEl-
mer, Waltham, MA) was used to spectrally unmix the image cubes
into individual channels corresponding to hematoxylin, DAB, and
the fluorochromes (Alexa Fluor 488, Alexa Fluor 647, Cy3).
Unmixing was based on the pure spectra of the respective
chromogens and fluorochromes.
Image processing
The spectral unmixing procedure results in multiple non-
overlapping channels including a nuclear channel. We employed a
hybrid segmentation algorithm that combines the algorithms
proposed by Al-Kofahi et al [31] and Lin et al [32] to segment
nuclei. The segmentation algorithm models the image intensities
as a mixture of Poisson distribution and finds a threshold value
based on minimum error thresholding. The initial binarization is
refined using Graph Cuts [33]. The binarized image is then
convolved with a Laplacian-of-Gaussian filter at different scales to
detect seeds and compute initial segmentations (via local
maximum clustering [34]) that are refined using a model based
approach. In the refinement stage, adjacent fragments that share
boundary pixels are merged and the scores of the merged nuclei
are compared against the scores of individual fragmented nuclei. If
the score of the merged nucleus is greater than the individual
scores, then the nuclei are merged together in the final
segmentation. The scores are evaluated using a training set of
accurately segmented nuclei. Interested readers can refer to [31]
and [32] for more details of the individual stages of the hybrid
algorithm. For each segmented nucleus, we generate a range of
‘‘intrinsic’’ features that quantify their intensity, shape, size and
chromatin texture (Table S1 in File S1) along with associative
features that describe their association with multiple proteins
across all the unmixed channels.
Active learning for logistic regression
Each cell is denoted by a vector of cell measurements - xi, where
the subscript i denotes the ith cell. Considering a binary
classification problem, the labels of the cells are denoted by yi
and +1 label indicates that the cell is an EC and a 21 label
indicates that the cell is a non-EC. Following a standard logistic
regression model notation, we can write
Figure 3. Venn diagrams for patterns of agreement in ccRCC20
dataset. Patterns of agreement between the classification calls made
by each of the three experts and the FARSIGHT-AL classification models
trained by them. The agreement was quantified based on a subset of
cells in the ccRCC20 image set with cells that were classified as non-EC
by all three experts being excluded in the analysis. (A) When classifying
cells in this subset as EC or non-EC, the three experts agreed with one
another only in ,64% of the cases. (B) The agreement in FARSIGHT-AL
classification models trained by each of the experts was ,74%. Trainer
2 exhibits the least degree of ‘‘idiosyncrasy’’ in terms of classification
calls and agrees better with trainer 1 than trainer 3.
doi:10.1371/journal.pone.0090495.g003
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P(yi Dxi)~s(yiwTxi),
Where P(:) denotes the probability of an event, w is a vector of
classifier parameters that need to be estimated and
s(p)~1=(1ze{p ) is the sigmoid function. For convenience, the
intercept term has been accommodated by setting the first element
of xito always be 1. Assuming that the distribution of cell features
are drawn independently and identically from the same distribu-
tion, the log-likelihood function can be written as
l(w)~
XN
i~1
ln (yiw
Txi), ð1Þ
where
P
indicates summation over all N cells being analyzed and
ln denotes the natural logarithm. In traditional supervised
learning, the user provides a labeled set of examples to the
algorithm with the goal of finding the value of w that maximizes
(1); i.e.,
woptimal~ argw max
XN
i~1
lns(yiw
Txi):
In the proposed method, training examples are selected actively
based on the Fisher information matrix and this approach is called
active learning. We denote the Fisher information matrix by Q
and by definition of the Fisher information matrix [35], we have
Q~Eyf
Ll
Lw
Ll
Lw
T
g,
where Ey denotes the expectation operator with respect to the cell
labels. It is well known that the inverse of the Fisher information
matrix is a lower bound of the covariance matrix of the
estimatedw. In particular, ½det (Q){1be a lower bound of the
product of variances of the elements inw. By selecting the cells that
maximize det (Q), we can reduce the variances or uncertainty in
the elements of w. For logistic regression, Q is given by
Table 2. Quantifying trainer agreement evaluation using Kappay (k) statistic.
Trainer-1 FARSIGHT-AL (1) Trainer-2 FARSIGHT-AL (2) Trainer-3 FARSIGHT-AL (3)
Trainer -1 1.000 0.926 0.850 0.915 0.789 0.848
FARSIGHT-AL(1) 0.926 1.000 0.822 0.894 0.763 0.846
Trainer -2 0.850 0.822 1.000 0.888 0.826 0.860
FARSIGHT-AL(2) 0.915 0.894 0.888 1.000 0.808 0.901
Trainer-3 0.789 0.763 0.826 0.808 1.000 0.856
FARSIGHT-AL(3) 0.848 0.846 0.860 0.901 0.856 1.000
yKappa Statistic is the ratio of observed agreement between raters to perfect agreement, controlling for agreement expected by chance alone. Refer to the ‘‘Kappa
Statistics and Inter-Observer Agreements’’ sub-section in the Methods section to understand how Kappa values are calculated. The values in the above table reflect the
agreement between the raters for EC classification in ccRCC20 image set. The diagonal values in the above table are all 1 as every rater agrees perfectly with himself/
herself.
doi:10.1371/journal.pone.0090495.t002
Figure 4. Background subtraction for analyte channels. To
correct for background DAB staining in Ki67 and pSTAT3 (A), an
extranuclear background subtraction algorithm was applied to the
spectrally unmixed analyte channel (B), resulting in a new, ‘‘back-
ground-subtracted’’ analyte channel (C). Images with little to no DAB
background (D) show almost no difference between the pre-
subtraction analyte channel (E) and the background-subtracted analyte
channel (F). Images in panels (A),(B), (C) display the same cropped
region from a sample image. Images in panels (D),(E), (F) display the
same cropped region from another sample image. The cropped regions
are of different sizes which is reflected in the calibration bars.
doi:10.1371/journal.pone.0090495.g004
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Q~
XN
i~1
s(wTxi)(1{s(w
Txi))xix
T
i :
The selection of training examples proceeds in a sequential
fashion where examples that maximize the determinant of the
Fisher information criterion are queried for their labels; i.e., the
algorithm queries the user for labls of those examples that
maximize, in every iteration, the value of the expression
detfQzs(wTxi)(1{s(wTxi))xixiTg. In the spirit of sequential
optimal experiment design [36], we use the value of w estimated
from the labeled data selected until the current iteration.
FARSIGHT-AL in auto-select mode uses L1-regularized logistic
regression [37] which promotes sparse solutions and sets w values
of irrelevant features to zero thereby effectively selecting the
features for classification. The maximization problem for training
this classifier is,
woptimal~ argmax (
XN
i~1
ln s(yiw
Txi){lDDwDD1),
where DD:DD1 denotes the L1 norm and l is a free parameter that can
be used to control the degree of sparsity; i.e., a greater value of l
results in large number of w values being set to zero resulting in
fewer features explaining the classification. To deal with the n on-
differentiability of the L1- norm, we use the eps-L1 approximation
to maximize the log-likelihood function. Finally, the Fisher
Information matrix in auto-select mode is given by
Q~
XN
i~1
s(wTxi)(1{s(w
Txi))xixi
T{diag(
leffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
(w2ze)3
q ),
where diag(:)denotes a diagonal matrix and eis a very small real
number (of the order 1029 ).
Kappa statistics and inter-observer agreements
Cohen’s Kappa (k) [38] is a measure of agreement between two
raters, ranging potentially from 21 to 1, with larger values
indicating better agreement. It is defined as the ratio of observed
agreement to perfect agreement, controlling for the level of
agreement that would be expected by chance alone (i.e., as if the
two ratings were independent). If we denote Po as the observed
proportion of classification calls that are the same between two
raters and Pe as the proportion of classification calls that would be
the same by chance given the observed data, then
K~
(Po{Pe)
(1{Pe)
,
The numerator in this expression represents the proportion of
observed agreement minus the agreement expected by chance
assuming the fractions of observed positive ratings in the two
classifiers, and the denominator represents the highest possible
agreement minus the agreement expected by chance. If the raters
agree as well as if they simply flipped coins i.e., completely
randomly, Po will equal Pe and k will be zero. Although in general
the interpretation of k depends on the prevalence of a positive
rating and the bias (the difference between raters in the proportion
of positive ratings), a k value of 0.6 or greater between raters is
generally regarded as substantial agreement.
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Supporting Information
Figure S1 Multispectral image of a multiplex-stained
ccRCC tumor with results of spectral unmixing. A clear
cell renal cell carcinoma (ccRCC) slide was stained for an analyte
(Ki67) and nuclei using chromogens DAB (brown) and hematox-
ylin (blue), respectively, and for antigens that mark different cells
types (CD34, SMA, CA IX) using different fluorochromes. After
spectral unmixing, the brightfield image (A) yielded hematoxylin
(B) and DAB (C) chromogen channels, which were used for
nuclear segmentation and analyte determination, respectively.
After spectral unmixing, the fluorescent image (D) yielded the
Alexa Fluor 488 (E), Cy3 (F) and Alexa Fluor 647 (G) channels,
which were used to stain CD34 (endothelial cell), SMA (pericyte)
and CA IX (tumor cell) antigens, respectively.
(TIF)
Figure S2 Comparison of FARSIGHT-AL performance
with other feature selection algorithms for UCI machine
learning breast cancer datasets. Mean classification accura-
cy of 25 independent simulations plotted as a function of number
of training examples for different automated feature selection
algorithms including FARSIGHT AL (blue lines) on the UCI
Breast Cancer Datasets. FARSIGHT-AL selected 50 training
examples sequentially based on the increase in information gain
whereas logistic regression was used to classify examples after
feature selection by PCA (green), T-Test (purple), MRMR
(Orange). Standard Logistic regression (red) with no feature
selection performs poorly compared to other algorithms. The bars
indicate standard error of the mean of classification accuracy.
(TIF)
Figure S3 Subcellular distribution of different analytes.
The diversity in the staining patterns of different analytes is
illustrated in the above figure. The nuclear stain appears blue in
color whereas the analyte stain appears brown. Ki67 (A) and
pSTAT3 (B) are predominantly nuclear bound whereas pERK (C)
IS found in both the cytoplasmic and nuclear regions.
(TIF)
Figure 5. Analysis of analyte expression for 22 ccRCC tumors. (A) Results of endothelial cell (EC) classification and analysis of EC analyte
expression performed on 22 ccRCC by Farsight-AL using the auto-select trainer 2 EC classification model and models for analyte classification specific
to each analyte with operator-defined thresholds. Shown are the proportion of total cells classified as EC (top) and of EC staining positively for Ki67,
p-ERK, and p-STAT3. Identifying codes for individual tumors are provided along the horizontal axis. EC proportions are represented by the median
(solid circles) and the 75th and 25th percentile (upper and lower bars) values for the 10–12 image set collected for each tumor-analyte. (B) Similar
results as in (A) for manual feature selection.
doi:10.1371/journal.pone.0090495.g005
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Figure S4 Comparison of ccRCC and non-ccRCC tu-
mors for hypervascularity. The whisker plot shows the
proportion of EC as a percentage of total number of cells in 22
ccRCC tumors (left) and 6 non-ccRCC tumors (right). In both the
panels, the dot and the whiskers follow standard notation i.e., the
dot indicates the median value of the proportion of cells and the
top and bottom whiskers indicate the 25th and 75th percentile.
Visual inspection of these plots suggests that the proportion of EC
is higher in the ccRCC case. Comparison of the median values
from each group using the Wilcoxon rank sum test revealed
statistically significant differences between the groups with a p-
value of 0.0015.
(TIF)
File S1 File containing Tables S1–S4.
(DOC)
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